论文部分内容阅读
目的探讨盐酸氨溴索雾化吸入治疗新生儿肺炎的疗效。方法选取80例肺炎患儿,按随机数字表法分为两组,对照组(39例)常规抗感染、止咳等综合治疗,观察组(41例)在对照组治疗基础上,给予盐酸氨溴索雾化吸入,观察并记录两组患者疗效、临床症状消失时间、红细胞压积、血液黏稠度及治疗期间不良反应情况,评价盐酸氨溴索雾化吸入对新生儿肺炎的疗效。结果治疗后观察组有效率高于对照组(P<0.05),观察组38例患儿,对照组28例患儿治疗后咳嗽、憋喘减轻,痰量减少;盐酸氨溴索雾化吸入治疗后,观察组患儿咳嗽、肺部湿啰音消失时间及平均住院时间明显缩短(P<0.05);治疗后观察组患者红细胞压积、血液黏稠度均低于对照组(P<0.05);治疗期间两组不良反应率无统计学差异。结论盐酸氨溴索雾化吸入对新生儿肺炎具有较好的治疗效果,能迅速改善肺炎症状,降低血液黏稠度,用药安全,值得临床推广使用。
Objective To investigate the efficacy of inhalation of ambroxol hydrochloride in the treatment of neonatal pneumonia. Methods Eighty children with pneumonia were randomly divided into two groups according to the random number table. The control group (39 cases) were given conventional anti-infective and cough-combing treatment. The observation group (41 cases) The effects of inhalation of ambroxol hydrochloride inhalation on neonatal pneumonia were evaluated by inhalation. The curative effect, disappearance of clinical symptoms, hematocrit, blood viscosity and adverse reactions during the treatment were observed and recorded. Results After treatment, the effective rate of the observation group was higher than that of the control group (P <0.05). In the observation group, 38 cases of children and the control group of 28 children were relieved of cough, suffocation and sputum volume after treatment. Ambroxol hydrochloride inhalation therapy After treatment, the cough in the observation group, the disappearance time of the lung wet rales and the average hospitalization time were significantly shorter (P <0.05). After treatment, the hematocrit and blood viscosity in the observation group were lower than those in the control group (P <0.05). There was no significant difference in adverse reactions between the two groups during treatment. Conclusion Ambroxol Hydrochloride inhalation has good therapeutic effect on neonatal pneumonia, can rapidly improve the symptoms of pneumonia, reduce blood viscosity, and is safe for use. It is worth to be popularized and used clinically.